Previous 10 | Next 10 |
2024-01-08 08:31:52 ET Summary The healthcare sector was flat in 2023 year as a result of some unique issues. Drug price regulation will be a serious challenge for the sector this year. Defensive healthcare industry groups should do well during the first half and biotechnology...
2024-01-07 04:45:00 ET Summary Suzhou Ribo Life Science formed a collaboration with Boehringer Ingelheim in a deal that could be worth up to $2 billion. Suzhou MediLink Therapeutics out-licensed global rights for its pre-clinical c-Mesenchymal epithelial transition factor ADC to R...
2024-01-06 08:15:00 ET Summary Global equity markets experienced a surge in 2023 driven by economic growth and investor confidence. US equity returns exceeded expectations despite concerns about higher rates, inflation, and geopolitical tension. In 2024, investors should focus...
2024-01-05 17:56:37 ET Summary Shorting and inverse bets don't work over time on average, making inverse funds like Direxion Daily S&P Biotech Bear 3X Shares ETF a big avoid. The LABD ETF is a triple-leveraged inverse ETF that focuses on the biotechnology sector and aims to pr...
2024-01-04 14:57:40 ET More on SPDR S&P Biotech ETF: Biopharmaceutical Stocks: The Rally Has Just Begun Get Ready For The New Biotech Bull Market Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Biotechs p...
2024-01-02 17:00:00 ET Summary Leveraged ETFs often underperform their underlying index due to beta-slippage. Monthly and yearly drift can be monitored to assess the performance of leveraged ETFs relative to their underlying index. ProShares UltraPro Dow30 (UDOW) has experienc...
2024-01-02 12:32:09 ET More on COVID vaccine makers BioNTech's Strategic Shift: Diversifying Into Cancer Therapeutics Novavax: Do Not Expect A Turnaround In 2024 BioNTech's COVID-19 Success Paves The Way For A Strong Drug Pipeline Moderna upgraded at Oppenhei...
2023-12-29 15:22:12 ET More on Moderna 2024 - Liquidia, Burford, And Roivant Moderna: MRNA-4157 Cancer Vaccine Data Points To A Future Beyond Spikevax Moderna, Inc. (MRNA) 2023 ESG Day Conference (Transcript) JN.1 Omicron strain becomes dominant COVID variant...
2023-12-29 14:12:19 ET Summary The biotech sector is finishing 2023 on a high after a difficult couple of years, buoyed by Big Pharma M&A activity. The SPDR® S&P Biotech ETF has been soaring as a result of the M&A spree. Despite a challenging year, there have ...
2023-12-28 15:21:17 ET More on Novavax Novavax: Do Not Expect A Turnaround In 2024 Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference (Transcript) Novavax: Less Is Less - Shrinking COVID Market Takes Its Toll (Rating Downgrade) JN.1 Omicr...
News, Short Squeeze, Breakout and More Instantly...
SPDR Series Trust S&P Biotech Company Name:
XBI Stock Symbol:
NYSE Market:
2024-07-08 11:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-18 13:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...